MedPath

Direct Mechanical Thrombectomy Versus Bridging Therapy

Phase 4
Completed
Conditions
Thrombectomy
Large-Artery Atherosclerosis (Embolus/Thrombosis)
Ischemic Stroke
Interventions
Device: Trevo and or Merci devices for stent retreival
Device: Penumbra system for stent aspiration
Registration Number
NCT05155540
Lead Sponsor
Alexandria University
Brief Summary

This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging therapy in patients with anterior circulation large vessel occlusion in a cohort of patients treated at the stroke unit of a single centre at Alexandria University in Egypt.

Detailed Description

This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging therapy in patients with anterior circulation large vessel occlusion in a cohort of patients treated at the stroke unit of a single centre at Alexandria University in Egypt. In the first arm, 17 patients were recruited and underwent direct mechanical thrombectomy without receiving recombinant tissue plasminogen activator. In the bridging therapy arm, 34 patients received first tissue plasminogen activator then underwent direct mechanical thrombectomy. The efficacy was evaluated by the NIHSS improvement 24 hours following stroke onset and the modified Rankin scale 3 months following stroke. Safety was assessed by the procedural complications rate especially the hemorhagic transformation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Patients with anterior ischemic stroke due to large vessel occlusion.
  • A previous autonomous modified Rankin Scale (mRS) of less than 2.
  • A National Institutes of Health Stroke Scale (NIHSS)≥4
  • A groin puncture within 4.5 hours of the neurological deficit onset.
Exclusion Criteria
  • Imaging documentation of intracranial haemorrhage
  • A premorbid mRS score of 2 or more
  • Absence of diffusion perfusion mismatch in CT perfusion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Direct mechanical thrombectomyTrevo and or Merci devices for stent retreivalDirect mechanical thrombectomy performed within 4.5 of stroke onset without giving intravenous recombinant tissue plasminogen activator.
Direct mechanical thrombectomyPenumbra system for stent aspirationDirect mechanical thrombectomy performed within 4.5 of stroke onset without giving intravenous recombinant tissue plasminogen activator.
Bridging therapyTrevo and or Merci devices for stent retreivalMechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg
Bridging therapyPenumbra system for stent aspirationMechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg
Bridging therapyrecombinant tissue plasminogen activatorMechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg
Primary Outcome Measures
NameTimeMethod
Complication ratewithin one week postoperatively

The rate and type of complications occuring postoperatively

Modified Rankin Scale score3 months

A measurement of functional independence following ischemic stroke

Secondary Outcome Measures
NameTimeMethod
The National Institutes of Health Stroke Scale (NIHSS) scoreat 24 hours postoperatively

A validated scale for assessment of neurological dysfunction associated with stroke

Trial Locations

Locations (1)

Alexandria University Faculty of Medicine

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath